Showing 261-270 of 7438 results for "".
Updates on Nitric Oxide As a Topical Anti-infective
https://practicaldermatology.com/topics/practice-management/updates-on-nitric-oxide-as-a-topical-anti-infective/21071/NO continues to show promise as a safe and effective topical treatment candidate for acne and other infectious dermatoses.Complex Adaptive Systems Approach: Continuous Quality Improvement Assessments Applied to Dermatology
https://practicaldermatology.com/topics/general-topics/complex-adaptive-systems-approach-continuous-quality-improvement-assessments-applied-to-dermatology/21103/Part II- Applied to Systemic Lupus ErythematosusThe Future of Atopic Dermatitis Therapy
https://practicaldermatology.com/topics/general-topics/the-future-of-atopic-dermatitis-therapy/21143/As new research elucidates the individual mechanisms of atopic dermatitis, the development of therapies that more directly influence the disease may change the scope of treatment.Ask An Expert: Establishing Yourself as an Expert
https://practicaldermatology.com/topics/practice-management/ask-an-expert-establishing-yourself-as-an-expert/18937/In this edition of NewDermMD's video series, host Adam Friedman, MD speaks with Neal Bhatia, MD about establishing one's expertise, becoming an educator, and finding a comfortable place working with industry, peers, and societies. Whether your interest is in cosmetic dermatology, acne, psoriasis, peValeant Acquires Salix; Actavis Changing Name
https://practicaldermatology.com/series/dermwire-tv/valeant-acquires-salix-actavis-changing-name/18963/Valeant expands its portfolio with the acquisition of GI market leader Salix. Actavis divests Doryx and considers a name change to Allergan. Kythera acquires rights for investigational hair therapies. And Cynosure's 532nm laser delivery system is FDA cleared for PicoSure.Otezla Approved for Plaque Psoriasis
https://practicaldermatology.com/topics/psoriasis/dermiretv-otezla-approved-for-plaque-psoriasis/19031/In this week's edition of DermWireTV from the publishers of Practical Dermatology® magazine and DermWire.com, a look at Celgene's Otezla for psoriasis--the first PDE4 inhibitor approved for plaque psoriasis. Plus, Ranbaxy's new dosage strengths of Absorica (isotretinoin), and Galderma's search for pThe Effects of the Great Recession on Medical Aesthetics
https://practicaldermatology.com/topics/general-topics/the-effects-of-the-great-recession-on-medical-aesthetics/21324/An analysis of how aesthetic physicians have been affected and insight on the pace of economic recovery.Part 2: Is Your Financial Advisor Working for You?
https://practicaldermatology.com/topics/practice-management/part-2-is-your-financial-advisor-working-for-you/21353/Important questions to ask to find out what your advisor is doing for you.Update on Topical Acne Therapy for Adult Women
https://practicaldermatology.com/topics/general-topics/update-on-topical-acne-therapy-for-adult-women/19166/Diane Berson, MD, FAAD discusses the approach to management of acne in the adult female patient, emphasizing the role of vehicle to affect the patient experience, promote adherence, and optimize outcomes. Bonus Material: Hormonal Therapy for Female Acne Bonus Material: Procedures for Adult Female AAvoiding Common Social Media Follies
https://practicaldermatology.com/topics/practice-management/avoiding-common-social-media-follies/21450/Despite offering a number of opportunities for promotion, social media also engender many potential pitfalls that physicians should take care to avoid.